Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Revatis logo — An innovative patented and minimally invasive approach for o...

Revatis

An innovative patented and minimally invasive approach for obtaining stem cells

Founded 2013 Belgium Belgium 14 employees Biotechnology, Health Care

General Information

Company Name Revatis
Founded Year 2013
Location Belgium Belgium
Employees 14
Industries Biotechnology, Health Care
Social

BounceWatch is an independent company data service, not affiliated with Revatis. To contact Revatis, visit revatis.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Revatis compare?

A PDF of Revatis and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Revatis soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Revatis

Revatis, founded in 2013 , is revolutionizing biomedical technology with its innovative patented approach for obtaining stem cells . The company's focus on research and development is evident through its commitment to delivering practical solutions that address real-world healthcare challenges. The patented technology for obtaining multipotent stem cells from muscle micro-biopsies represents a significant breakthrough in regenerative medicine . These stem cells have the potential to address various medical issues, from tissue repair to immune modulation, in both veterinary and human applications. Moreover, Revatis is not only limited to its current achievements but is continuously exploring new avenues, including extracellular vesicle production , 3D cell culture using platelet lysates , and proprietary enzymatic reagents for cell release. These efforts are aimed at developing practical, effective solutions that can improve patient outcomes. The company's collaboration with leading institutions and experts is central to its approach, leveraging collective expertise to accelerate the development and adoption of innovative therapies. Based in Belgium , Revatis is truly at the forefront of driving progress in biomedical technology. As an investor, it’s exciting to see the potential for this innovative approach to significantly impact the healthcare industry and patient outcomes. With its dedication to research, practicality, and collaboration, Revatis presents an enticing opportunity for those looking to support advancements in regenerative medicine and biomedical solutions. Therefore, it would be intriguing to monitor any future developments and potential investments in this promising company.

Business keywords: Biomedical Technology, Regenerative Medicine, Stem Cell Research, Innovative Therapies, Medical Innovations, Cell Therapy, Extracellular Vesicles, 3D Cell Culture, Tissue Repair, Immune Modulation, Collaborative Partnerships, Patented Technology, Minimally Invasive Procedures

No funding data available for Revatis yet.

Revatis Alternatives & Competitors

View All Alternatives
Revatis vs
Aglaris Ltd Group
Aglaris Ltd Group United Kingdom

Aglaris Ltd. together with Aglaris Cell, Changing Cellular Manufacturing: More productive, more reli...

Grant
11 employees
Biotechnology, Health Care
Revatis vs
PrimeCell Bioscience, a.s.
PrimeCell Bioscience, a.s. Czech Republic

Měníme klasické paradigma léčby

4 employees
Biotechnology, Health Care
Revatis vs
Aptus Bioreactors
Aptus Bioreactors United States

Regenerating Tissues, for Life

3 employees
Biotechnology, Health Care
View all alternatives

FAQ About Revatis

An innovative patented and minimally invasive approach for obtaining stem cells
Revatis was founded in 2013.
Revatis is headquartered in Belgium.
Revatis operates in Biotechnology and Health Care. Its work centres on Biomedical Technology, Regenerative Medicine, Stem Cell Research and Innovative Therapies.
Revatis has approximately 14 employees.
Top alternatives and competitors to Revatis include Aglaris Ltd Group, PrimeCell Bioscience, a.s., Aptus Bioreactors, InGeneron, StemSight - Vision Unlimited. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Revatis and Aglaris Ltd Group are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Revatis, https://www.bouncewatch.com/company/revatis, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout